Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kamal V Patel

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Inflammatory Bowel Diseases|April 30, 2013
Hair loss in patients with inflammatory bowel diseaseKamal V Patel, Paul Farrant, Jeremy D Sanderson, et al.
Postgraduate Medical Journal|October 24, 2015
Budd-Chiari syndrome: investigation, treatment and outcomesRishi M Goel, Emma L Johnston, Kamal V Patel, et al.
Nature Reviews. Gastroenterology & Hepatology|November 4, 2016
Patient optimization for surgery relating to Crohn's diseaseKamal V Patel, Amir A Darakhshan, Nyree Griffin, et al.
Inflammatory Bowel Diseases|August 9, 2017
Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standing Crohn's DiseaseViraj C Kariyawasam, Mark G Ward, Paul A Blaker, et al.
United European Gastroenterology Journal|June 8, 2017
Thioguanine in inflammatory bowel disease: Long-term efficacy and safetyMark G Ward, Kamal V Patel, Viraj C Kariyawasam, et al.
Journal of Crohn'S & Colitis|October 22, 2025
Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trialNurulamin M Noor, Neil Davies, Warda Tahir, et al.
Inflammatory Bowel Diseases|August 22, 2015
Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohn's DiseaseMark G Ward, Viraj C Kariyawasam, Sathis B Mogan, et al.
Journal of Crohn'S & Colitis|May 22, 2026
Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trialMegha Bhandari, Mohmmed Tauseef Sharip, Nurulamin M Noor, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2021
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control studyShaji Sebastian, Gareth J Walker, Nicholas A Kennedy, et al.
BMJ Open Gastroenterology|February 1, 2022
Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort studyShaji Sebastian, Kamal V Patel, Jonathan P Segal, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Inflammatory Bowel Diseases|April 30, 2013
Hair loss in patients with inflammatory bowel diseaseKamal V Patel, Paul Farrant, Jeremy D Sanderson, et al.
Postgraduate Medical Journal|October 24, 2015
Budd-Chiari syndrome: investigation, treatment and outcomesRishi M Goel, Emma L Johnston, Kamal V Patel, et al.
Nature Reviews. Gastroenterology & Hepatology|November 4, 2016
Patient optimization for surgery relating to Crohn's diseaseKamal V Patel, Amir A Darakhshan, Nyree Griffin, et al.
Inflammatory Bowel Diseases|August 9, 2017
Thiopurines Dosed to a Therapeutic 6-Thioguanine Level in Combination with Adalimumab Are More Effective Than Subtherapeutic Thiopurine-based Combination Therapy or Adalimumab Monotherapy During Induction and Maintenance in Patients with Long-standing Crohn's DiseaseViraj C Kariyawasam, Mark G Ward, Paul A Blaker, et al.
United European Gastroenterology Journal|June 8, 2017
Thioguanine in inflammatory bowel disease: Long-term efficacy and safetyMark G Ward, Kamal V Patel, Viraj C Kariyawasam, et al.
Journal of Crohn'S & Colitis|October 22, 2025
Anti-tumor necrosis factor treatment from diagnosis is more effective and less costly than conventional "step-up" care for patients with active Crohn's disease: a cost-effectiveness analysis from the PROFILE trialNurulamin M Noor, Neil Davies, Warda Tahir, et al.
Inflammatory Bowel Diseases|August 22, 2015
Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohn's DiseaseMark G Ward, Viraj C Kariyawasam, Sathis B Mogan, et al.
Journal of Crohn'S & Colitis|May 22, 2026
Magnetic resonance imaging-based simplified MaRIA scores are associated with future surgery in Crohn's disease, but modest correlation with ileo-colonoscopic inflammation limits their utility in clinical trials: results from the PROFILE trialMegha Bhandari, Mohmmed Tauseef Sharip, Nurulamin M Noor, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2021
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control studyShaji Sebastian, Gareth J Walker, Nicholas A Kennedy, et al.
BMJ Open Gastroenterology|February 1, 2022
Ambulatory care management of 69 patients with acute severe ulcerative colitis in comparison to 695 inpatients: insights from a multicentre UK cohort studyShaji Sebastian, Kamal V Patel, Jonathan P Segal, et al.
Pageof 3